Our results provided valuable evidence that the PPAR pathway took part in the fibrosis regression regulation, and suggested that stimulation of PPAR pathway might serve as a potential therapeutic strategy for human liver fibrosis. Here, PPARA is linked to Hepatic fibrosis.